Say what you want about AstraZeneca’s castoff strategy, but it helped drive another earnings beat for the lacking-in-sales drugmaker to kick off the year.
The whistle continues to blow in a case alleging AstraZeneca defrauded Medicare by playing down the risks of its antipsychotic drug Seroquel, just not as loudly.
AstraZeneca now has a one-stop shop for patients. It's a new all-in-one pharma app that offers savings card access, refill reminders and customer care contacts for the company's top brands.
AstraZeneca has prevailed: The first jury to hear a Seroquel case decided that the warnings on its label were adequate, so patients and doctors should have had enough information about the drug's
